ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Historical Holders from Q1 2017 to Q3 2025

Symbol
ANAB on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
27,712,115
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
31,635,003
Holdings value
$968,941,233
% of all portfolios
0.002%
Number of holders
164
Number of buys
75
Number of sells
-75
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 7.7% +35% $49,025,259 +$14,013,859 2,368,370 +40% Point72 Asset Management, L.P. 31 Mar 2025
BlackRock, Inc. 6.2% -27.5% $39,347,471 -$13,405,817 1,900,844 -25.4% BlackRock, Inc. 31 Mar 2025
MORGAN STANLEY 6.3% $48,136,102 1,845,002 Morgan Stanley 30 Jun 2025
VANGUARD GROUP INC 5.23% +5.8% $34,133,610 +$448,995 1,537,550 +1.3% The Vanguard Group 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 5.1% $28,851,776 1,426,893 Millennium Management LLC 16 Sep 2025
GOLDMAN SACHS GROUP INC 4.5% -14% $38,314,646 -$10,329,933 1,251,294 -21.2% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025
First Light Asset Management, LLC 3.12% -57.4% $26,474,603 -$42,907,347 864,618 -61.8% Mathew P. Arens 30 Sep 2025
FMR LLC 0.9% -88.3% $5,091,861 -$33,068,368 254,211 -86.7% FMR LLC 30 May 2025

Institutional Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31,635,003 $968,941,233 -$154,408,495 $30.62 164
2025 Q2 36,775,405 $816,417,703 -$61,528,593 $22.2 146
2025 Q1 39,955,702 $742,780,741 +$106,646,664 $18.59 150
2024 Q4 35,417,634 $468,934,603 -$87,874,690 $13.24 133
2024 Q3 33,628,905 $1,126,906,586 +$123,178,333 $33.5 158
2024 Q2 29,795,998 $746,647,480 +$18,365,650 $25.06 133
2024 Q1 29,220,936 $658,049,704 -$20,954,780 $22.52 132
2023 Q4 30,178,929 $646,434,520 +$661,774 $21.42 117
2023 Q3 30,319,401 $544,539,672 -$1,742,551 $17.96 116
2023 Q2 30,230,678 $614,916,059 -$16,322,967 $20.34 116
2023 Q1 31,038,362 $675,357,489 -$44,703,594 $21.76 112
2022 Q4 32,881,839 $1,018,995,107 -$10,549,644 $30.99 114
2022 Q3 32,565,742 $830,751,663 +$39,360,338 $25.51 109
2022 Q2 31,163,975 $632,623,400 +$28,483,649 $20.3 117
2022 Q1 29,681,010 $735,000,699 +$13,953,506 $24.74 124
2021 Q4 27,753,009 $964,436,533 +$8,862,117 $34.75 132
2021 Q3 27,612,274 $748,805,223 -$4,361,131 $27.12 123
2021 Q2 27,792,119 $720,641,941 -$34,119,008 $25.93 117
2021 Q1 29,170,513 $628,617,724 +$26,204,184 $21.55 116
2020 Q4 27,945,751 $600,836,464 -$16,682,226 $21.5 129
2020 Q3 29,118,815 $429,506,449 -$16,534,668 $14.75 127
2020 Q2 29,995,726 $670,116,259 -$17,219,808 $22.34 117
2020 Q1 31,226,700 $441,231,854 +$44,124,506 $14.13 112
2019 Q4 28,278,193 $459,515,291 -$210,904,567 $16.25 119
2019 Q3 29,041,948 $1,016,180,867 -$48,935,396 $34.99 118
2019 Q2 30,188,598 $1,703,071,412 +$118,485,533 $56.42 126
2019 Q1 29,116,728 $2,126,815,017 +$19,403,624 $73.05 128
2018 Q4 28,960,221 $1,847,302,433 -$11,161,189 $63.79 120
2018 Q3 28,571,805 $2,850,575,697 +$379,454,311 $99.77 127
2018 Q2 24,854,220 $1,765,626,873 +$925,670 $71.04 121
2018 Q1 24,343,157 $2,533,621,510 +$62,752,765 $104.08 134
2017 Q4 23,775,515 $2,394,657,180 +$692,566,246 $100.72 116
2017 Q3 17,730,856 $619,647,150 +$143,400,869 $34.95 70
2017 Q2 13,703,868 $327,947,635 -$2,477,474 $23.93 51
2017 Q1 13,764,320 $381,565,000 +$374,641,000 $27.75 48